MEDIZINISCHE HOCHSCHULE HANNOVER - Germany 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:500-600
Total Number of Projects:400-500
2019
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:200-300
Total Number of Projects:300-400
2018
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:300-400
Total Number of Projects:300-400
Networking Rank (Reputation):300-400
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:200-300
Total Number of Projects:600-700
Networking Rank (Reputation):> 1000
Partner Constancy:800-900
Project Leadership Index:100-200
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2013
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:100-200
Total Number of Projects:63
Total Project Funding:200-300
Partner Constancy:51
Project Leadership Index:55
Diversity Index:39
2012
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:200-300
Total Number of Projects:61
Total Project Funding:200-300
Networking Rank (Reputation):300-400
Networking Rank (Reputation):300-400
Partner Constancy:46
Project Leadership Index:66
Diversity Index:37
2011
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:200-300
Total Number of Projects:100-200
Total Project Funding:200-300
Networking Rank (Reputation):100-200
Partner Constancy:300-400
Project Leadership Index:200-300
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:600-700
Total Number of Projects:300-400
Total Project Funding:600-700
Networking Rank (Reputation):700-800
Partner Constancy:500-600
Project Leadership Index:51
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Total Project Funding:200-300
Networking Rank (Reputation):300-400
Partner Constancy:300-400
Project Leadership Index:600-700
Diversity Index:500-600
2008
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:600-700
Total Number of Projects:300-400
Total Project Funding:700-800
Networking Rank (Reputation):400-500
Partner Constancy:200-300
Project Leadership Index:700-800
Diversity Index:700-800
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:800-900
Total Number of Projects:400-500
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:400-500
Project Leadership Index:500-600
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2021-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 91
As coordinator: 9
As participant: 71
Sole participant: 11
Coordinator / Participant Ratio: 0.13*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 3.791.835 30.293.582 2.988.551 3 4
2019 1.999.500 98.821.483 7.243.748 1 8
2018 5.340.912 22.732.427 3.581.629 2 5
2017 0 29.825.928 1.853.374 5
2016 5.968.850 18.328.283 2.707.797 1 3
2015 6.930.703 35.204.348 5.234.790 3 5
2014 100.000 150.000 142.800 1 1
2013 3.340.211 50.885.341 6.587.278 1 10
2012 8.726.286 37.813.929 4.880.961 2 10
2011 6.097.000 67.204.494 3.932.864 3 13
2010 3.171.324 25.609.941 3.046.212 3 7

Networking:

Partners:

Institution:Projects [No]:
UNIVERSITY COLLEGE LONDON17
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE14
KATHOLIEKE UNIVERSITEIT LEUVEN11
UNIVERSITAIR MEDISCH CENTRUM UTRECHT10
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V9
GOTTFRIED WILHELM LEIBNIZ UNIVERSITAET HANNOVER7
KAROLINSKA INSTITUTE7
ACADEMISCH ZIEKENHUIS LEIDEN6
LUNDS UNIVERSITET6
MEDIZINISCHE UNIVERSITAET WIEN6
MILTENYI BIOTEC6
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD6
THE UNIVERSITY OF MANCHESTER6
UNIVERSITY OF NEWCASTLE UPON TYNE6
ACADEMISCH ZIEKENHUIS GRONINGEN5
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS5
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE5
CHARITE UNIVERSITAETSMEDIZIN BERLIN5
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM5
INSERM TRANSFERT5
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN5
MOSAIQUES DIAGNOSTICS5
REGION HOVEDSTADEN5
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA5
UNIVERSITAET ZUERICH5
UNIVERSITEIT MAASTRICHT5
UNIVERSITY OF OSLO5
CONSIGLIO NAZIONALE DELLE RICERCHE4
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER4
FUNDACION PARA LA INVESTIGACION MEDICA APLICADA4
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT4
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE4
KING'S COLLEGE LONDON4
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN4
NOVARTIS PHARMA4
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON4
SERVICIO MADRILENO DE SALUD4
STICHTING KATHOLIEKE UNIVERSITEIT4
TECHNISCHE UNIVERSITAET MUENCHEN4
THE QUEEN'S UNIVERSITY OF BELFAST4
UNIVERSITA DEGLI STUDI DI PADOVA4
UNIVERSITAET ULM4
UNIVERSITAETSKLINIKUM FREIBURG4
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF4
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN4
UNIVERSITY OF GLASGOW4
VRIJE UNIVERSITEIT BRUSSEL4
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM3
CHALMERS TEKNISKA HOEGSKOLA AB3
COMMISSARIAT A L'ENERGIE ATOMIQUE3
CORLIFE OHG3
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE3
F HOFFMANNLA ROCHE3
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA3
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA3
GENETHON3
GOETEBORGS UNIVERSITET3
INSTITUT PASTEUR3
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI3
ITAE SUOMEN YLIOPISTO3
KLINIKUM DER UNIVERSITAET REGENSBURG3
OSLO UNIVERSITETSSYKEHUS HF3
OSPEDALE PEDIATRICO BAMBINO GESU3
SANOFIAVENTIS3
THE HEBREW UNIVERSITY OF JERUSALEM3
THE UNIVERSITY OF EDINBURGH3
THE UNIVERSITY OF SHEFFIELD3
UNIVERSITA DEGLI STUDI DI CATANIA3
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ3
UNIVERSITAT AUTONOMA DE BARCELONA3
UNIVERSITAT ZU LUBECK3
UNIVERSITE DU LUXEMBOURG3
UNIVERSITE LIBRE DE BRUXELLES3
UNIVERSITE PARIS DESCARTES3
UNIVERSITY OF BIRMINGHAM3
UNIVERSITY OF DUNDEE3
UNIVERSITY OF LEEDS3
ACADEMIC MEDICAL CENTRE AMSTERDAM2
ACS BIOMARKER BV2
ASPHALION SL2
AZIENDA OSPEDALIERA DI PADOVA2
AZIENDA OSPEDALIEROUNIVERSITARIA DI PARMA2
BATAVIA BIOSCIENCES BV2
BELGISCH INSTITUUT VOOR DE VERKEERSVEILIGHEID VZW INSTITUT BELGE POURLA SECURITE ROUTIERE ASBL2
BIOCRATES LIFE SCIENCES2
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL2
CONCENTRIS RESEARCH MANAGEMENT2
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS2
CSEM CENTRE SUISSE D'ELECTRONIQUE ET DE MICROTECHNIQUE SA RECHERCHE ET DEVELOPPEMENT2
DEMOCRITUS UNIVERSITY OF THRACE2
EFPC2
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH2
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS2
FAKULTNI NEMOCNICE BRNO2
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS2
GENEWERK2
GENEXPLAIN2
GENOSAFE SAS2
GIE DE RECHERCHES ET D'ETUDES PSA RENAULT2
GREAT ORMOND STREET HOSPITAL FOR CHILDREN NHS FOUNDATION TRUST2

Constancy:

Total number of partners: 1041
Partner loyalty:
Frequent Partner: (> 2 projects): 352
Rare Partner: 689
Frequent / Rare Partner Ratio: 0.51

Project overview:

Start dateProjectacronymrolefundingpartners
2020-11-01Accelerating Research & Development for Advanced Therapies ARDATparticipant11.773.00034
2020-10-01Spinal Muscular Atrophy (SMA) beyond motoneuron degeneration: multi-system aspects SMABEYONDcoordinator2.142.7358
2020-07-01Noncoding RNA MEG3 inhibitor for Heart Failure Treatment MEGFIBcoordinator150.0001
2020-02-01Communication for Children with Hearing Impairment to optimise Language Development Comm4CHILDparticipant4.094.92010
2020-01-01THERVACB: A THERAPEUTIC VACCINE TO CURE HEPATITIS B TherVacBparticipant10.425.68618
2020-01-01From iPSC-Macrophage Biology Towards Regenerative Therapies Targeting Respiratory Infections iPSC2Therapycoordinator1.499.1001
2020-01-01Action Leveraging Evidence to Reduce perinatal morTality and morbidity in sub-Saharan Africa ALERTparticipant3.999.9768
2019-12-01Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies imSAVARparticipant10.999.31628
2019-09-01Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions 3TRparticipant40.273.19270
2019-06-01TRAIN-HEART TRAIN-HEARTparticipant3.940.38916
2019-05-01Gene therapy of inherited and acquired hearing loss iHEARcoordinator1.999.5001
2019-01-01European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development ESCALONparticipant3.283.47513
2019-01-01Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials RESHAPEparticipant13.137.39610
2019-01-01CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease CardioReGenixparticipant14.839.77413
2019-01-01Medical Device Obligations Taskforce MDOTparticipant8.348.63414
2019-01-01MyPal: Fostering Palliative Care of Adults and Children with Cancer through Advanced Patient Reported Outcome Systems MyPalparticipant3.999.30916
2018-11-01Promoting smart specialization at the Technical University of Moldova by developing the field of Novel Nanomaterials for BioMedical Applications through excellence in research and twinning NanoMedTwinparticipant999.6936
2018-10-01Promoting patient safety by a novel combination of imaging technologies for biodegradable magnesium implants MgSafeparticipant3.956.39913
2018-06-01MAnufacturing of TUmour-REactive Natural Killer cells MATURE-NKcoordinator3.351.66214
2018-06-01Hanover experimental lung research project XHaLecoordinator1.989.2501
2018-02-01An in silico-based approach to improve the efficacy and precision of drug REPurpOsing TRIALs for a mechanism-based patient cohort with predominant cerebro-cardiovascular phenotypes REPO-TRIALparticipant5.536.77313
2018-01-01Adeno-Associated Virus Vector-Mediated Liver Gene Therapy for Crigler-Najjar Syndrome CureCNparticipant6.249.10411
2018-01-01Stem-cell based gene therapy for recombination deficient SCID (RECOMB) RECOMBparticipant5.990.46017
2017-10-01Aerodynamic and Flexible Trucks for Next Generation of Long Distance Road Transport AEROFLEXparticipant9.534.77925
2017-09-01Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics GLIOTRAINparticipant3.836.77223
2017-06-01Targeting the transcriptional landscape in infant AML iAML-lncTARGETparticipant1.499.7501
2017-01-01HARMONIzation and integrative analysis of regional, national and international Cohorts on primary Sjögren’s Syndrome (pSS) towards improved stratification, treatment and health policy making HarmonicSSparticipant9.998.75039
2017-01-01Towards enduring mouse resources and services advancing research into human health and disease INFRAFRONTIER2020participant4.955.87730
2016-05-01Training network providing cutting-EDGE knowlEDGE on Herpes Virology and Immunology EDGEparticipant3.961.9439
2016-03-01Synergy-based Open-source Foundations and Technologies for Prosthetics and RehabilitatiOn SoftProparticipant7.440.02614
2016-01-01DevelopIng Genetic medicines for Severe Combined Immunodeficiency (SCID) SCIDNETparticipant6.926.31312
2016-01-01Tools and TECHNOlogies for Breakthrough in hEArt Therapies TECHNOBEATcoordinator5.968.8508
2015-12-01microRNA biomarkers in an innovative biophotonic sensor kit for high-specific diagnosis miRNA-DisEASYparticipant445.5007
2015-10-01novel bioreactor Platform for reprOducible, Scalable ExpansIonand cardiac DifferentiatiON of hiPSC in suspension culture POSEIDONcoordinator159.4611
2015-08-01iABC Programme IABC PROGRAMMEparticipant24.331.60922
2015-07-01Personalized Nanomedicines for Leukemia Patients PNANOMEDparticipant1.499.7501
2015-06-01Development and disease of the renal tract RENALTRACTparticipant3.137.3778
2015-06-01Exploring selected long non-coding RNAs as diagnostics and therapeutic targets for heart failure LONGHEARTcoordinator1.816.2501
2015-05-01Safety CaUsation, Benefits and Efficiency SafetyCubeparticipant5.790.11117
2015-01-01Aortic Valve Replacement using Individualised Regenerative Allografts: Bridging the Therapeutic Gap ARISEcoordinator4.954.9929
2014-04-01Immune and Neuromodulation Mediated by Alphaherpesviruses INMAcoordinator100.0001
2014-01-01Individualized Implant Placement IIPparticipant150.0002
2013-12-01Parasite glycobiology and anti-parasitic strategies GLYCOPARparticipant3.450.85612
2013-11-01Targets and biomarkers for antiepileptogenesis EPITARGETparticipant11.999.97518
2013-10-01ACTive Implant for Optoacoustic Natural sound enhancement ACTIONparticipant2.992.0007
2013-10-01Advances in Small Trials dEsign for Regulatory Innovation and eXcellence ASTERIXparticipant2.999.8817
2013-09-01Targeting cardiac fibrosis for heart failure treatment FIBRO-TARGETSparticipant6.000.00011
2013-09-01ATMP GMP Open Access Research Alliance - AGORA AGORAparticipant497.4328
2013-04-01Lymph node homing of immune cells via afferent lymphatics – mechanisms and immune response LYMPHATICS-HOMINGparticipant2.491.2001
2013-03-01Biomarkers of renal graft injuries in kidney allograft recipients BIOMARGINparticipant6.000.00013

overview shows latest 50 from 91 projects (2010-01-01 - 2021-12-31)
A full list of projects can be found here:

Alias institution names:

  • MEDIZINISCHE HOCHSCHULE HANNOVER